Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Soy appears to protect against development of breast cancer

Evidence is growing from animal and human studies that genistein, a potent chemical found in soy, protects against development of breast cancer - but only if consumed during puberty, says a Georgetown University Medical Center researcher in the British Journal of Cancer published online today.

10 Apr 2008

Takeda to acquire Millennium for $8.8 billion

Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement pursuant to which Takeda will acquire Millennium for approximately $8.8 billion through a cash tender offer of $25.00 per share.

10 Apr 2008

Stopping a cancer trial early: is it for the benefit of patients or industry?

New research has identified a growing trend for trials of new cancer treatments to be stopped prematurely before the therapies' risks and benefits have been properly evaluated.

9 Apr 2008

Benefits of some cancer drugs exaggerated because trials were stopped early

Italian scientists say the benefits of some cancer drugs may be exaggerated as a rising number of trials are stopped early.

9 Apr 2008

Roswell Park Cancer Institute awarded three-years funding for ovarian cancer vaccine

The Ovarian Cancer Research Fund has awarded a $900,000 research grant to Kunle Odunsi, MD, Department of Gynecologic Oncology, and his colleagues at Roswell Park Cancer Institute (RPCI) to collaborate on developing a promising vaccine to unleash the power of the immune system against cancer.

7 Apr 2008

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Cephalon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA (bendamustine hydrochloride) for Injection for the treatment of patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow disease, on March 20, 2008.

7 Apr 2008

Disparities in postmastectomy breast reconstruction

In a new study examining disparities in postmastectomy breast reconstruction, researchers at Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) in Boston, Mass., concluded that lack of patient-provider discussion may contribute to socioeconomic, age and race-related inconsistencies in the use of breast reconstruction after mastectomy.

3 Apr 2008

Fasting for two days protects healthy cells against chemotherapy

The chemotherapy worked as intended on cancer, extending the lifespan of mice injected with aggressive human tumors, reported a group led by Valter Longo of the University of Southern California.

1 Apr 2008

Study finds improvement in the care of children with cancer at the end of life

Expanded use of palliative care services is associated with enhanced communications between families and caregivers, improved symptoms management, and better quality of life for children dying from cancer, according to study by researchers at Dana-Farber Cancer Institute and Children's Hospital Boston.

31 Mar 2008

PET confirmed as valuable cancer diagnostic and disease-staging tool

The recent release of data by the National Oncologic PET Registry (NOPR) showing that positron emission tomography (PET) produced scans revealing disease at a molecular level, which then caused physicians to change treatment plans for more than one-third of participating patients, has corroborated decades of nuclear medicine research.

28 Mar 2008

MRI's high false positive rate has little impact on women's choice of preventive mastectomy

Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease.

26 Mar 2008

Red wine antioxidant resveratrol kills cancer

Rochester researchers showed for the first time that a natural antioxidant found in grape skins and red wine can help destroy pancreatic cancer cells by reaching to the cell's core energy source, or mitochondria, and crippling its function.

26 Mar 2008

Siemens installs first HD-PET technology at UT Southwestern

Siemens Healthcare has announced the official release and world's first clinical installation of HD-PET technology at UT Southwestern Medical Center in Dallas.

From Siemens Healthineers 25 Mar 2008

New mathematical model provides new understanding of cell signaling

Looking for answers in the bright light of day, rather than the confined beam of a street light at night.

25 Mar 2008

Cancer treatments in phase 3 trials successful up to half of the time

About one-fourth to one-half of new cancer treatments that reach assessment in phase 3 randomized clinical trials are eventually proven successful, according to a report in the March 24 issue of Archives of Internal Medicine.

25 Mar 2008

Review of supplement use among US cancer patients

Many of the 10 million cancer patients in the US are taking nutritional supplements, but an accurate assessment of the frequency is not well appreciated.

24 Mar 2008

Treating wife's stress help men with prostate cancer

When a couple is dealing with cancer, a partner's psychological distress might drag down the well-being of either person, according to a new study of 168 married couples.

24 Mar 2008

Shorter radiotherapy courses for breast cancer just as safe and effective

British researchers say when it comes to treating breast cancer in women, shorter courses of radiation at a lower overall dose appear to be just as safe and effective as the standard treatment delivered over a longer period of time.

21 Mar 2008

Review of supplement use among US cancer patients

Many of the 10 million cancer patients in the US are taking nutritional supplements, but an accurate assessment of the frequency is not well appreciated.

20 Mar 2008

Shorter radiotherapy courses can benefit breast cancer patients

A LOWER total dose of radiotherapy, delivered in fewer, larger treatments has been shown to be as effective as the international standard of a higher total dose delivered over a longer time to treat women with early breast cancer according to new research published in the Lancetand Lancet Oncology.

20 Mar 2008